Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Christoph Heuck, MD
Global Medical Head
Janssen Research & Development LLC
Poster(s):
117: Efficacy, Safety, Pharmacokinetic (PK) & Pharmacodynamic (PD) Support for Talquetamab Weekly (QW) & Biweekly (Q2W) Dosing in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Analyses From MonumenTAL-1
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT
126: Evaluation of Talquetamab Drug-Drug Interaction Potential as a Result of Cytokine Release Syndrome in Patients With Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT
